Viewing Study NCT01167166

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:37 PM

Ignite Modification Date: 2025-12-30 @ 12:44 PM

Study NCT ID: NCT01167166

Status: COMPLETED

Last Update Posted: 2017-06-26

First Post: 2010-07-19

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)

Sponsor: Traws Pharma, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module